respiratory viruses

Moderna, mRNA, flu vaccine, phase 3, respiratory viruses, RSV vaccine

Moderna’s mRNA flu vaccine shows phase 3 success, plans for combo shots by 2025

Anika Sharma

Moderna has achieved significant progress in its quest to develop an mRNA flu vaccine, with the updated mRNA-1010 version successfully ...